Navigation Links
Hollings Cancer Center Creates $1 Million Endowed Chair for Breast Cancer Research and Treatment with Gift from the Spaulding-Paolozzi Foundation
Date:10/2/2007

CHARLESTON, S.C., Oct. 2 /PRNewswire/ -- The Medical University of South Carolina Hollings Cancer Center has received $500,000 from the Spaulding- Paolozzi Foundation to create the Countess Alicia Paolozzi Distinguished Endowed Chair in Breast Cancer Diagnosis, Treatment and Research. Hollings Cancer Center will provide matching funds of $500,000 for the endowed chair.

"The $1 million Chair will allow Hollings Cancer Center to recruit an outstanding breast cancer clinician and scientist to find new ways of diagnosing and treating the disease," said Andrew S. Kraft, M.D., Director of Hollings Cancer Center. "Great strides have been made in diagnosing and treating breast cancer, but we have a long way to go. A gift like this from the Spaulding-Paolozzi Foundation enables us to continue our mission of preventing, detecting and treating breast cancer in South Carolina."

The purpose of this Chair is to leverage the considerable research capabilities of MUSC and Hollings Cancer Center in the following ways:

-- To better understand the origins of breast cancer

-- To develop preventative strategies for breast cancer through molecular

diagnostics

-- To lead the effort to promote minority breast health through

collaborative work with the Hollings Cancer Center Disparities programs

-- To bring cutting edge novel treatments to the people of South Carolina

-- To provide exceptional patient care and clinical leadership to all the

physicians of South Carolina

"On behalf of the Board of Directors of the Spaulding-Paolozzi Foundation, we are thrilled to support the incredible work of the Hollings Cancer Center," said Nigel Redden, President of the Spaulding-Paolozzi Foundation. "We had absolutely no hesitation in making this contribution and are proud to help."

The Spaulding-Paolozzi Foundation was founded by Countess Alicia Paolozzi to support efforts concerning the environment, the sustainability of agriculture, and issues involving women and the elderly.

About Hollings Cancer Center

Hollings Cancer Center offers state-of-the-art diagnostic capabilities, therapies and surgical techniques and has multidisciplinary clinics that involve surgeons, medical oncologists, radiation therapists, radiologists, pathologists, psychologists and many other specialists seeing patients under one roof. Multidisciplinary care is provided in disease specific clinics such as thoracic, breast, head & neck, genitourinary, gastrointestinal, hematological, neurological, and pediatric cancers. The Hollings Cancer Center is the largest academic-based cancer program in South Carolina. The Hollings Cancer Center is currently a developing National Cancer Institute designated cancer center and has more than $35M in cancer research funding. More than 1,000 people are currently participating on a cancer clinical trial at HCC. For more information, please visit http://www.hcc.musc.edu.

About MUSC

Founded in 1824 in Charleston, The Medical University of South Carolina is the oldest medical school in the South. Today, MUSC continues the tradition of excellence in education, research, and patient care. MUSC educates and trains more than 3,000 students and residents, and has nearly 10,000 employees, including 1,300 faculty members. As the largest non-federal employer in Charleston, the university and its affiliates have collective annual budgets in excess of $1.3 billion. MUSC operates a 600-bed medical center, which includes a nationally recognized Children's Hospital and a leading Institute of Psychiatry. For more information on academic information or clinical services, visit http://www.musc.edu or http://www.muschealth.com.


'/>"/>
SOURCE The Medical University of South Carolina
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Vitamin B12 can help in detecting cancers
6. More Accurate "PROSTATE CANCER" Test can save Unnecessary Biopsies
7. Consensus on "Combination Therapy" for Breast Cancer
8. Cancers of Colon & Rectum linked to Cigarette Smoking
9. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
10. The Cancer Rumour mill working over time
11. Want skin cancer? Please have a cigarette
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids ... sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited ... all ages; it is a non-competitive, non-timed event, which is all about having fun ...
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/12/2017)... WILMINGTON, Del. (PRWEB) , ... October 12, 2017 ... ... technology and advisory services for healthcare compliance program management, will showcase a range ... and National Association for Assisted Living (NCAL) Convention and Expo to be held ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
Breaking Medicine Technology: